Guided Therapeutics (GTHP) Other financing activities (2021 - 2025)

Guided Therapeutics' Other financing activities history spans 4 years, with the latest figure at -$32000.0 for Q4 2025.

  • On a quarterly basis, Other financing activities changed N/A to -$32000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$33000.0, a 3200.0% decrease, with the full-year FY2025 number at $30000.0, up 3.45% from a year prior.
  • Other financing activities hit -$32000.0 in Q4 2025 for Guided Therapeutics, down from -$31000.0 in the prior quarter.
  • Over the last five years, Other financing activities for GTHP hit a ceiling of $722000.0 in Q3 2022 and a floor of -$722000.0 in Q4 2022.
  • Historically, Other financing activities has averaged $4833.3 across 4 years, with a median of -$500.0 in 2024.
  • The widest YoY moves for Other financing activities: up 1064.52% in 2022, down 1064.52% in 2022.
  • Tracing GTHP's Other financing activities over 4 years: stood at $62000.0 in 2021, then crashed by 1264.52% to -$722000.0 in 2022, then skyrocketed by 95.71% to -$31000.0 in 2024, then fell by 3.23% to -$32000.0 in 2025.
  • Business Quant data shows Other financing activities for GTHP at -$32000.0 in Q4 2025, -$31000.0 in Q3 2024, and $30000.0 in Q2 2024.